Services on Demand
- Cited by SciELO
- Access statistics
- Cited by Google
- Similars in SciELO
- Similars in Google
Print version ISSN 0365-0596
An. Bras. Dermatol. vol.87 no.3 Rio de Janeiro May/June 2012
Exuberant clinical presentation of probable Malassezia folliculitis in a young nonimmunosuppressed patient*
Apresentação clinica exuberante de provável foliculite por Malassezia em jovem imunocompetente
Silvio Alencar MarquesI; Sabrina Bortoletto Gomes da SilvaII; Rosangela Maria Pires de CamargoIII; Hamilton Ometto StolfIV; Mariangela Esther Alencar MarquesV
ILecturer/Assistant Professor - Head of the Dermatology and Radiotherapy Department of the Medical School of Botucatu, Paulista State University "Julio de Mesquita Filho" (Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Julio de Mesquita Filho" - FMB - UNESP) - Botucatu (SP), Brazil
IIResident Physician of Dermatology, Teaching Hospital of the Medical School of Botucatu, Paulista State University "Julio de Mesquita Filho" (Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Julio de Mesquita Filho" - FMB - UNESP) - Botucatu (SP), Brazil
IIIBiologist - responsible for the laboratory of Mycology of the Dermatology and Radiotherapy Department of the Medical School of Botucatu, Paulista State University "Julio de Mesquita Filho" (Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Julio de Mesquita Filho" - FMB - UNESP) - Botucatu (SP), Brazil
IVPhD in Medicine - Assistant Professor of the Dermatology and Radiotherapy Department of the Medical School of Botucatu, Paulista State University "Julio de Mesquita Filho" (Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Julio de Mesquita Filho" - FMB - UNESP) - Botucatu (SP), Brazil
VLecturer/Assistant Professor - Pathology Department of the Medical School of Botucatu, Paulista State University "Julio de Mesquita Filho" (Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Julio de Mesquita Filho" - FMB - UNESP) - Botucatu (SP), Brazil
Malassezia folliculitis is an inflammatory disorder observed in both immunocompetent and immunosuppressed patients. The authors describe an unusual and exuberant presumed case affecting the face, trunk and upper limbs of a 12-year-old nonimmunosuppressed patient. Although the agent was not identified by culture, the clinical and histopathological aspects plus the response to specific treatment support the diagnosis of Malassezia folliculitis. The only possible predisponent cause observed on the patient was greasy skin. Repetitive cultures were negative. Treatment with itraconazol promoted apparent cure, however, the patient relapsed twelve months later.
Keywords: folliculitis; Malassezia; skin; skin manifestations; spores, fungal
Foliculite por Malassezia é processo inflamatório observado em pacientes imunocompetentes e imunossuprimidos. Os autores relatam um provável caso exuberante e incomum comprometendo a face, tronco e membros superiores de paciente de 12 anos de idade, não imunossuprimido. Embora o agente não tenha sido cultivado, os achados clínicos e histopatológicos aliados à resposta terapêutica sugerem o diagnóstico de foliculite por Malassezia. A única possivel causa predisponente demonstrada no paciente foi a pele oleosa. Tentativas de cultivo do agente foram negativas. O tratamento com itraconazol promoveu cura aparente, entretanto, houve recaída após 12 meses.
Palavras-chave: esporos fúngicos; foliculite; Malassezia; manifestações cutâneas; pele
Malassezia folliculitis (M.folliculitis), previously known as Pityrosporum folliculitis, was recognized as a specific disease by Potter in 1973.1 It has been described by some authors as a common disease in both young and middle-aged patients. 2 It has been interpreted as an infection of the hair follicle or as an inflammatory process according to different authors.1- 4 It occurs as an acneiform eruption presenting mild to moderate pruritus predominantly on the chest, upper back, and shoulders.1 Many patients with M. folliculitis have been following anti-acne regimens before correct diagnosis. Therefore, patients presenting an acneiform eruption not improving with specific treatment must be investigated for Malassezia folliculitis. The authors report an exuberant and unusual presumed clinical case in a nonimmunosuppressed patient without any other predisponent causes than his greasy skin.
A 12-year-old male patient with a two-month history of severe acneiform eruption was seen at our hospital unit. He had been treated with tetracyclines and systemic corticosteroid after a presumptive diagnosis of acne vulgaris. As no improvement was observed, the patient was referred to our service and complained of pruritus, worse in the warm days. His past medical history was unremarkable and no medications had been taken previously. On clinical examination monomorphic acneiform skin lesions were observed on his face, trunk and upper limbs (Figures 1 and 2). A greasy skin plus few pustular and comedolike lesions were also observed. Two punch-biopsies were performed and showed the same picture of a suppurative folliculitis. The pilosebaceous follicles appeared dilated, with keratinous plug, containing amorphous cellular debris, many inflammatory cells and globular structures (Figures 3 and 4). PAS and silver methenamine stain were positive to oval, simple budding yeast-like cells, consistent with Malassezia spp. (Figure 5). Specimens from additional punch biopsy collected for culture were negative. The diagnosis of the patient was supported by histopathologi-cal analyses, which did not reveal mycelial forms and showed abundant Malassezia yeasts in the follicles.
The patient was treated with itraconazole 200mg daily for two months with almost complete disappearance of all lesions. However, there was a relapse 12 months later when, once again, itraconazole 200mg/daily proved efficient.
Malassezia folliculitis has been considered as an inflammatory skin disorder for some authors and as an infection of the hair follicle by others and reported more frequently in young and middle-aged male patients.1-4 As Malassezia yeasts are commensals in normal skin the positive cultures do not necessarily imply that the fungus is the etiological agent. However, the presence of large numbers of yeasts in the follicle and around it associated with the rich presence of inflammatory cells, sometimes promoting the formation of small localized abscesses and response to antifungal treatment has provided sufficient elements to consider the disorder as an individualized disease.1,2 It is interesting that in cases of Malassezia folliculitis mycelia elements are not observed.1 This may suggest that the conversion to mycelia form may not be necessary to promote inflammation and clinical disease.1 In our case the exuberant clinical aspect associated with the intensity of the inflammatory process, not responsive to the previous corticosteroid treatment, suggested that the Malassezia yeasts were promoting a real infectious process. Comorbidities have been associated with M. folliculitis, such as seborrheic dermatitis in 40% of cases, acne vulgaris in 27% and pityriasis versicolor in 6%.2 The differential diagnosis varies according to the presence of comorbidities like HIV-infection; in these patients the differential diagnosis would be among M. folliculitis and other papular eruptions such as the papulopruritic eruption of HIV, HIV-associated eosinophilic folliculitis and suppurative folliculitis of bacterial etiology.3 In this particular patient, the first hypothesis was a corticosteroid induced acneiform eruption, despite the clinical history indication that the lesions already existed before the corticosteroid treatment.
Although the pathophysiological phenomena in Malassezia folliculitis are unknown, Hill et al.4 observed that the overgrowth of Malassezia yeasts in the follicle is a secondary event caused by occlusion by hyperkeratosis. The inflammatory reaction observed in the follicle may be the result of the ability of a Malassezia lipase to hydrolyse triglycerides into free fatty acid, as well as a demonstration that Malassezia species can induce the production of inflammatory cytokines in human epidermal keratinocytes via Tolllike receptor 2 observed in vitro. 5
It has been recently shown that the Malassezia species identified in the follicle causing M. folliculitis were the same species identified on healthy skin of cases and controls. According to Azaka et al.6 the species identified in 32 cases of M. folliculitis were M. globosa, M. restricta and M. sympodialis - the most common. The same study showed that the composition of Malassezia microbiota on apparently healthy skin of patients with Malassezia folliculitis was the same as that identified in the skin of healthy patients. Previous studies have shown that the predominant species in healthy skin of normal individuals are M. globosa and M. sympodialis.7 Framil et al, working with samples of patients with pityriasis versicolor in Brazil identified M. sympodialis as the most frequent (39.0%), followed by M. furfur (19.3%%), M. globosa (26.8%%) and M. slooffiae (4.9%%). 8 It must be highlighted that it is difficult to isolate the causative agents, even using the Dixon agar medium; the molecular methods could be an option when available.
A seven-day course of itraconazole 200mg/daily proved, in a double blind placebo-controlled study, to be efficient in treating 13 patients with M. folliculitis.9 Based on this previous trial in addition to recognizing the potential hepatotoxic adverse effect when using ketoconazole, the authors chose itraconazol as their treatment option. In the literature, topical ketoconazole, oral ketoconazole alone or in combination with topical ketoconazole promoted cure in respectively 12%, 75% and 75% of 26 patients, but recurrence was observed within 3 to 4 months after the end of treatment with these regimens.10 Alternative treatments
such as photodynamic therapy for those with poor response or adverse effects of antifungal drug have been proposed. Although this case report is based on a single patient, we suggest that skin biopsies should be done in cases of atypical acneiform eruption occurring in pre-adolescent, nonimmunosuppressed patients.
1. Potter BS, Burgoon CF, Johnson WC. Pityrosporum folliculitis. Report of seven cases and review of the Pityrosporum organism. Arch Dermatol. 1973;107:388-91. [ Links ]
2. Bäck O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis, a common disease of the young and middle aged. J Am Acad Dermatol. 1985;12:56-61. [ Links ]
3. Budavari JM, Grayson W. Papular follicular eruption in human immunodeficiency virus-positive patients in South Africa. Int J Dermatol. 2007;46:706-10. [ Links ]
4. Hill MK, Goodfield JD, Rodgers FG, Crowley JL, Saihan EM. Skin surface electron microscopy in Pityrosporum folliculitis: the role of follicular occlusion in disease and the response to oral ketoconazole. Arch Dermatol. 1990;126:181-4. [ Links ]
5. Baroni A, Orlando M, Donnarumma G, Farro P, Iovene MR, Tufano MA, et al. Tolllike receptor 2 (TLR-2) mediates intracellular signaling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res. 2006;297:280-8. [ Links ]
6. Akaza N, Akamatsu H, Sasaki Y, Kishi M, Mizutani H, Sano A, et al. Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol. 2009;47:618-24. [ Links ]
7. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 2000;38:337-41. [ Links ]
8. Framil VMS, Melhem MSC, Szesz MW, Corneta EC, Zaitz C. Pitiríase versicolor: isolamento e identificação das principais espécies de Malassezia. An Bras Dermatol. 2010;85:111-4. [ Links ]
9. Parsad D, Saini R, Negi KS. Short-term treatment of Pityrosporum folliculitis: a Double blind placebo-controlled study. J Eur Acad Dermatol Venereol. 1998;11:188-90. [ Links ]
10. Lévy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B. Malassezia folliculitis:characteristics and therapeutic response in 26 patients. Ann Dermatol Venereol. 2007;134:823-8. [ Links ]
Silvio Alencar Marques
Departamento de Dermatologia e Radioterapia. Faculdade de Medicina de Botucatu
Campus Universitário de Rubião Jr
18618-970 Botucatu - São Paulo, SP
Received on 11.04.2011.
Approved by the Advisory Board and accepted for publication on 01.06.2011.
Conflict of interest: None
Financial funding: None
* Study carried out at the Dermatology and Radiotherapy Department of the Medical School of Botucatu, Paulista State University "Julio de Mesquita Filho" (Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Julio de Mesquita Filho" - FMB - UNESP) - Botucatu (SP), Brazil.